| Novo Nordisk Pharma AG - Esperoct 5000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 67156 | | 07 | | Esperoct 5000 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD02 | | Coagulation Factor Viii | | 21.11.2024 | | |
| | Composition | | Praeparatio cryodesiccata: turoctocogum alfa pegolum 5000 U.I., histidinum, saccharum, polysorbatum 80, natrii chloridum corresp. natrium 14.16 mg, methioninum, calcii chloridum dihydricum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, pro vitro.
Solvens: natrii chloridum corresp. natrium 14.16 mg, aqua ad iniectabile q.s. ad solutionem pro 4 ml. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | Lyophilisate and solvent | | | | | | Active Agent | Dose |
|---|
| Turoctocogum alfa Pegolum | 5000 UI |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum ad Ph | | Calcium Chloride | | Histidine | | Methionine | | Sodium Chloride | | Natrii Hydroxidum ad Ph | | Polysorbatum 80 | | Saccharum |
|
| Solvens | | Lyophilisate and solvent | | | | | | | | | Inactive agents |
|---|
| Sodium Chloride |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 007 | | PR | PR | B | | No |
|
|
